Shanghai Allist Pharmaceuticals Co., Ltd. Stock
Equities
688578
CNE100005XJ7
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
60.85 CNY | -1.47% | -7.89% | +46.06% |
Sales 2023 | 2.01B 279M | Sales 2024 * | 2.96B 410M | Capitalization | 27.38B 3.79B |
---|---|---|---|---|---|
Net income 2023 | 645M 89.33M | Net income 2024 * | 1.04B 144M | EV / Sales 2023 | 9.32 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 9.25 x |
P/E ratio 2023 |
29.1
x | P/E ratio 2024 * |
26.4
x | Employees | 870 |
Yield 2023 |
0.96% | Yield 2024 * |
0.82% | Free-Float | 34.03% |
1 day | -1.47% | ||
1 week | -7.89% | ||
Current month | -1.98% | ||
1 month | +31.68% | ||
3 months | +45.99% | ||
6 months | +64.46% | ||
Current year | +46.06% |
Managers | Title | Age | Since |
---|---|---|---|
Jin Hao Du
CEO | Chief Executive Officer | 70 | 04-03-21 |
Feng Xu
BRD | Director/Board Member | 59 | 16-12-31 |
Jie Hu
BRD | Director/Board Member | 49 | 19-06-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Yan
BRD | Director/Board Member | 42 | 19-11-27 |
Jin Hao Du
CEO | Chief Executive Officer | 70 | 04-03-21 |
Rong Gang Xie
BRD | Director/Board Member | 39 | 19-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 60.85 | -1.47% | 6,506,604 |
24-05-13 | 61.76 | -3.71% | 10,498,960 |
24-05-10 | 64.14 | -0.76% | 10,536,670 |
24-05-09 | 64.63 | +0.02% | 9,733,446 |
24-05-08 | 64.62 | -2.18% | 9,710,229 |
End-of-day quote Shanghai S.E., May 13, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.06% | 3.79B | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.61% | 21.25B | |
-5.66% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- 688578 Stock